THE STUDY OF THE ACTIVATION OF MTORC1 AND ITS SUBSTRATE P70S6K INVOLVED IN TYPE 2 DIABETES MELLITUS AND ONCOGENETIC PROCESSES

Autor: Vatseba T. S., Sokolova L. K., Pushkarev V. V., Kovzun O. I., Pushkarev V. M., Tronko M. D.

Publikováno v: Східноукраїнський медичний журнал, Vol 8, Iss 2, Pp 182-190 (2020)

Introduction. Pathogenetic factors of diabetes may affect the activity of intracellular systems of oncogenesis and metabolism regulation, one of which is PI3K/Akt/mTORC1. Macrophages and lymphocytes are involved in the pathogenesis of diabetes and ca

Externí odkaz: https://doaj.org/article/8f581d0a6fe542c28ba489b9383f7d26

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Колоректальный рак и рак поджелудочной железы у больных с сахарным диабетом 2 типа. Исследование влияния инсулинотерапии

Autor: Vatseba, T. S., Sokolova, L. K., Pushkarev, V. M.

Publikováno v: Clinical Endocrinology and Endocrine Surgery; № 3 (2020); 38-46
Clinical Endocrinology and Endocrine Surgery. Клиническая эндокринология и эндокринная хирургия; № 3 (2020); 38-46
Clinical Endocrinology and Endocrine Surgery. Клінічна ендокринологія та ендокринна хірургія; № 3 (2020); 38-46

Patients with type 2 diabetes have increased cancer risk. The study of the role of antidiabetic drugs in the processes of oncogenesis, in particular insulin therapy, continues. Objective — to investigate the influence of insulin therapy on the inci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::507917f025095bef9314ad60d7d122da
http://jcees.endocenter.kiev.ua/article/view/213114

Effects of COVID-19 and diabetes mellitus on apolipoprotein A1 level in the blood plasma of patients.

Autor: Pushkarev, V. V., Sokolova, L. K., Cherviakova, S. A., Belchina, Yu. B., Bigun, M. V., Kovzun, O. I., Pushkarev, V. M., Tronko, M. D.

Publikováno v: International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal; 2021, Vol. 17 Issue 5, p411-417, 7p

The effect of metformin treatment on the level of GLP-1, NT-proBNP and endothelin-1 in patients with type 2 diabetes mellitus.

Autor: Sokolova, L. K., Belchina, Yu. B., Pushkarev, V. V., Cherviakova, S. A., Vatseba, T. S., Kovzun, O. I., Pushkarev, V. M., Tronko, M. D.

Publikováno v: International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal; 2020, Vol. 16 Issue 8, p616-621, 6p